-
Current and new antitumor necrosis factor agents in perspective.
Kennedy Institute of Rheumatology, Imperial College of Science, Technology and Medicine, London, UK. r.maini@imperial.ac.uk
PMID: 15228614 [PubMed - indexed for MEDLINE]
-
Cited by 2 PubMed Central articles
-
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, et al.
PLoS Med. 2007 Sep; 4(9):e278.
[PLoS Med. 2007]
-
ReviewAetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27.
Vähämiko S, Penttinen MA, Granfors K.
Arthritis Res Ther. 2005; 7(4):136-41. Epub 2005 May 26.
[Arthritis Res Ther. 2005]